Below are the top 10 rebounding Mid Cap stocks. These companies business
outlook has improved a lot in the past 52 weeks. One Chinese company (MPEL) is
on the list. Pharmasset, Inc. (NASDAQ:VRUS) is the 1st best rebounding stock in
this segment of the market. It has risen 473% from its 52-week low. It is now
trading at 98% of its 52-week high. CVR Energy, Inc. (NYSE:CVI) is the 2nd best
rebounding stock in this segment of the market. It has risen 237% from its
52-week low. It is now trading at 85% of its 52-week high. Apco Oil & Gas
International Inc. (NASDAQ:APAGF) is the 3rd best rebounding stock in this
segment of the market. It has risen 211% from its 52-week low. It is now trading
at 83% of its 52-week high. Valhi, Inc. (NYSE:VHI) is the 4th best rebounding
stock in this segment of the market. It has risen 211% from its 52-week low. It
is now trading at 86% of its 52-week high. IPG Photonics Corporation
(NASDAQ:IPGP) is the 5th best rebounding stock in this segment of the market. It
has risen 198% from its 52-week low. It is now trading at 75% of its 52-week
high. Accretive Health, Inc. (NYSE:AH) is the 6th best rebounding stock in this
segment of the market. It has risen 196% from its 52-week low. It is now trading
at 75% of its 52-week high. Lululemon Athletica inc. (NASDAQ:LULU) is the 7th
best rebounding stock in this segment of the market. It has risen 181% from its
52-week low. It is now trading at 91% of its 52-week high. Golar LNG Limited
(USA) (NASDAQ:GLNG) is the 8th best rebounding stock in this segment of the
market. It has risen 177% from its 52-week low. It is now trading at 81% of its
52-week high. Melco Crown Entertainment Ltd (ADR) (NASDAQ:MPEL) is the 9th best
rebounding stock in this segment of the market. It has risen 167% from its
52-week low. It is now trading at 72% of its 52-week high. Universal Display
Corporation (NASDAQ:PANL) is the 10th best rebounding stock in this segment of
the market. It has risen 164% from its 52-week low. It is now trading at 89% of
its 52-week high.
No comments:
Post a Comment